Fins Neuro (1-516-478-8304)
Clinical Resources
Mona Stecker Becomes President of the American Association of Neurosicence Nurses

Recent Papers

LINK TO RECENT PAPERS BY FINS MEMBERS

Veterans Brain Health Awareness Program Sponsored by the Alzheimer Foundation of America

Link To Alzheimer Foundation of AMerical Veterans Brain Health  Awareness

The Aducanumab Controversy in Alzheimer's Disease

The recent FDA approval of the first possilbly disease modifying treatment for Alzheimer's Disease is controversial and warrants significant discussion. I am including the links below to help start a discussion.
FDA Announcement of Approval of Aducanumab
Comments from Noted Alzheimer Researcher Allison Reiss
Data on Aducanumab from Biogen

Challenges in Alzheimer's Disease and Dementia

NEW APPROACHES IN DEMENTIA

EEG Conferences

EEG Clinical conferences

News and Useful Links

American Academy of Neurology
American Medical Association
American Federation for Medical Research
American Society for NeurophysioloGic Monitoring
Alzheimer's Foundation of America
American Association of Neuroscience Nurses

Newsletters

NewsletterApril2021

Clinical Resources

Clinical Resources
Fresno Institute Of Neuroscience
Enhancing NeuroScience Care through Collaboration and Diligence
Services
  • Clinical Neurology Care
  • Neurophysiology Services
  • Research
  • Education
  • Consulting
  • Manuscript Preparation
Location
Headquarters 1558 E Shadow Creek Dr Fresno, Ca 93730
NOTICE TO PATIENTSMedical doctors are licensed and regulated by the Medical Board of California. To check up on a license or to file a complaint go to www.mbc.ca.gov, email licensecheck@mbc.ca.gov, or call (800) 633-2322.
Contact
Notice to Patients: The Open Payments database is a federal tool used to search payments made by drug and device companies to physicians and teaching hospitals. It can be found at https://openpaymentsdata.cms.gov.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.